EDMONTON, ALBERTA--(Marketwire - Sept. 11, 2007) - Ceapro Inc. (TSX VENTURE:CZO) a Canadian growth-stage biotechnology company is delighted to announce that Gilles Gagnon, with 25 years experience in healthcare and pharmaceutical organizations, most recently as President and CEO of AEterna Zentaris, has joined the Board, effective immediately. His extensive managerial experience, especially in mergers and acquisitions, as well as his inside knowledge of the pharma world will aid Ceapro in executing its growth strategy - to be a global leader in developing and commercializing products for human and animal health markets.
